A Phase II Basket Trial of Dual Anti–CTLA-4 and Anti–PD-1 Blockade in Rare Tumors (DART SWOG 1609) in Patients with Nonpancreatic Neuroendocrine TumorsSandip Pravin Patel, Razelle Kurzrock, Jourdain Hayward et al.|Clinical Cancer Research|2020Cited by 326
Trends in survival of patients with primary plasma cell leukemia: a population-based analysisWilson I. Gonsalves, Shaji Kumar, Robert A. Kyle et al.|Blood|2014Cited by 139